These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 7638629

  • 1. Polycythemia rubra vera.
    Bilgrami S, Greenberg BR.
    Semin Oncol; 1995 Aug; 22(4):307-26. PubMed ID: 7638629
    [Abstract] [Full Text] [Related]

  • 2. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
    Ellis JT, Peterson P, Geller SA, Rappaport H.
    Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR.
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [Abstract] [Full Text] [Related]

  • 4. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S, Stock W, Godwin J, Fisher SG.
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [Abstract] [Full Text] [Related]

  • 5. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases].
    Sánchez Fayos J, Prieto E, Román A, Soto de Ozaeta C, Nevado I, Richart A, Chica E, Loscertales J, Calabuig T, Benítez J, Outeiriño J.
    Sangre (Barc); 1996 Dec; 41(6):447-57. PubMed ID: 9148422
    [Abstract] [Full Text] [Related]

  • 6. [Polycythaemia vera--diagnosis and therapy].
    Lechner K, Geissler K, Gisslinger H.
    Wien Klin Wochenschr; 1999 Aug 20; 111(15):582-9. PubMed ID: 10483672
    [Abstract] [Full Text] [Related]

  • 7. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
    Bai J, Shao ZH, Liu H, Shi J, He GS, Cao YR, Cui ZZ, Wu YH, Sun J, Tian Z, Jia HR, Qian LS, Yang TY, Yang CL.
    Chin Med J (Engl); 2004 May 20; 117(5):668-72. PubMed ID: 15161531
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
    Mossuz P, Girodon F, Donnard M, Latger-Cannard V, Dobo I, Boiret N, Lecron JC, Binquet C, Barro C, Hermouet S, Praloran V.
    Haematologica; 2004 Oct 20; 89(10):1194-8. PubMed ID: 15477203
    [Abstract] [Full Text] [Related]

  • 9. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Haematologica; 2001 Apr 20; 86(4):368-74. PubMed ID: 11325641
    [Abstract] [Full Text] [Related]

  • 10. Prediction of clinical course in patients with idiopathic erythrocytosis by endogenous erythroid colony assay but not by serum erythropoietin levels.
    Shih LY, Lee CT, Ou YC.
    Exp Hematol; 1997 Apr 20; 25(4):288-92. PubMed ID: 9131002
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and therapy of polycythemia vera.
    Lengfelder E, Merx K, Hehlmann R.
    Semin Thromb Hemost; 2006 Apr 20; 32(3):267-75. PubMed ID: 16673281
    [Abstract] [Full Text] [Related]

  • 12. [Polycythemia vera: clinical aspects and course in 86 patients].
    Egli F, Wieczorek A, Niemöller M, Rhyner K.
    Schweiz Med Wochenschr; 1988 Dec 31; 118(52):1969-75. PubMed ID: 3217777
    [Abstract] [Full Text] [Related]

  • 13. Polycythemia vera: a review.
    Golden C.
    Clin J Oncol Nurs; 2003 Dec 31; 7(5):553-6. PubMed ID: 14603552
    [Abstract] [Full Text] [Related]

  • 14. Expertise-based management in essential thrombocythemia and polycythemia vera.
    Finazzi G, Barbui T.
    Cancer J; 2007 Dec 31; 13(6):372-6. PubMed ID: 18032974
    [Abstract] [Full Text] [Related]

  • 15. In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders.
    Weinberg RS.
    Semin Hematol; 1997 Jan 31; 34(1):64-9. PubMed ID: 9025164
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD).
    Murphy S.
    Thromb Haemost; 1997 Jul 31; 78(1):622-6. PubMed ID: 9198227
    [Abstract] [Full Text] [Related]

  • 17. Treatment of polycythemia vera.
    Silver RT.
    Semin Thromb Hemost; 2006 Jun 31; 32(4 Pt 2):437-42. PubMed ID: 16810620
    [Abstract] [Full Text] [Related]

  • 18. Management of patients with polycythaemia vera: results of a survey among Swedish haematologists.
    Andreasson B, Löfvenberg E, Westin J.
    Eur J Haematol; 2005 Jun 31; 74(6):489-95. PubMed ID: 15876252
    [Abstract] [Full Text] [Related]

  • 19. Polycythemia vera: diagnosis and treatment 2002.
    Berlin NI.
    Expert Rev Anticancer Ther; 2002 Jun 31; 2(3):330-6. PubMed ID: 12113056
    [Abstract] [Full Text] [Related]

  • 20. [Polycythemia vera, clinical aspects and disease course].
    Heilmann E, Köhler T.
    Fortschr Med; 1978 May 11; 96(18):941-6. PubMed ID: 648997
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.